GOG Foundation
J

Maintenance Therapy Clinical Trials in Newly Diagnosed Ovarian Cancer Are Positive for Prolonged PFS With BRCA Deriving the Most PFS Benefit

By GOG Foundation FEATURING Joyce Liu
By GOG Foundation FEATURING Joyce Liu
0 views
January 22, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:42
ImmunoGen

Best Practices for the management of ocular adverse events associate…

Feat. K. Lamoreau

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn

Recommended

AUTOPLAY
09:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…

Feat. E. Hamilton
09:06
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecologic Oncology Updates"

Feat. R. Salani
14:45
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Gynecological Cancers Highlights"

Feat. M. Raza Mirza
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
04:43
Treatment Approach for Advanced Ovarian Cancer

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:50
Fengting Yan

Year in Review: Ovarian Cancer

27:14
David Tan

Management of Recurrent Ovarian Clear Cell Carcinoma

25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
17:20
UCLA Health

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Beds…

Feat. G. Konecny
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
19:30
Miami Cancer Institute Precision Oncology Symposium

Precision Oncology in the Management of Ovarian Cancer

Feat. D. Dizon
05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
23:53
Masonic Cancer Center, University of Minnesota

Overview of Ovarian Cancer Updates

Feat. J. Mattson
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin
17:33
AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Fol…

Feat. S. Lewin
17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux
09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer